Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
ITI Pharma & Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited10.620815088824.0561
Domestic EquitiesDivi's Laboratories Limited7.78723100117.6380
Domestic EquitiesApollo Hospitals Enterprise Limited5.81441777513.1695
Domestic EquitiesMax Healthcare Institute Limited5.696811575512.9032
Domestic EquitiesCohance Lifesciences Limited5.056413027911.4528
Domestic EquitiesTorrent Pharmaceuticals Limited4.59132886110.3992
Domestic EquitiesFortis Healthcare Limited4.1258963609.3450
Domestic EquitiesAurobindo Pharma Limited3.6185756148.1958
Domestic EquitiesAster DM Healthcare Limited3.44511244627.8031
Domestic EquitiesLupin Limited3.0420360506.8902
Domestic EquitiesAlkem Laboratories Limited2.9827124536.7558
Domestic EquitiesMankind Pharma Limited2.9276272246.6309
Domestic EquitiesWockhardt Limited2.7560411766.2423
Domestic EquitiesNeuland Laboratories Limited2.565739795.8113
Domestic EquitiesDr. Reddy's Laboratories Limited2.4466452855.5415
Domestic EquitiesCipla Limited2.2086332775.0025
Domestic EquitiesAbbott India Limited2.185416904.9500
Domestic EquitiesHealthcare Global Enterprises Limited1.7897630134.0536
Domestic EquitiesSai Life Sciences Limited1.7280454743.9139
Domestic EquitiesSumitomo Chemical India Limited1.4170601883.2095
Domestic EquitiesFDC Limited1.3852709333.1374
Domestic EquitiesIPCA Laboratories Limited1.3294224883.0111
Domestic EquitiesLaurus Labs Limited1.3106352632.9684
Domestic EquitiesRainbow Childrens Medicare Limited1.2063201502.7323
Domestic EquitiesSBI Life Insurance Company Limited1.1724148302.6555
Domestic EquitiesGlenmark Pharmaceuticals Limited1.1690135592.6477
Domestic EquitiesOrchid Pharma Limited1.1238362582.5453
Domestic EquitiesSupriya Lifescience Limited1.0726333242.4295
Domestic EquitiesStandard Glass Lining Technology Ltd1.01971335982.3096
Domestic EquitiesOnesource Specialty Pharma Limited1.0179125272.3055
Domestic EquitiesSagility India Limited0.97135156852.1999
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited0.928479062.1028
Domestic EquitiesPoly Medicure Limited0.9271107792.0999
Domestic EquitiesLinde India Limited0.864531351.9580
Domestic EquitiesCaplin Point Laboratories Limited0.856598671.9400
Domestic EquitiesSRF Limited0.835767041.8929
Domestic EquitiesShilpa Medicare Limited0.8242247841.8667
Domestic EquitiesNavin Fluorine International Limited0.716035091.6217
Domestic EquitiesUPL Limited0.6720232091.5220
Domestic EquitiesBiocon Limited0.6667442841.5101
Domestic EquitiesZydus Lifesciences Limited0.6264144491.4187
Domestic EquitiesPiramal Pharma Limited0.5073601051.1490
Domestic EquitiesSyngene International Limited0.4718171591.0687
Total 98.4801 223.0569
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)1.5199 3.4426
Total 1.5199 3.4426
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.